Literature DB >> 15272919

Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years.

J Kvetny1, P E Heldgaard, E M Bladbjerg, J Gram.   

Abstract

OBJECTIVE: Mild thyroid failure is associated with an increased risk for development of atherosclerosis, but whether subclinical hypothyroidism is related to risk for cardiovascular disease is controversial. The purpose of the present study was to examine a possible association between subclinical hypothyroidism and cardiovascular disease.
DESIGN: Cross-sectional study of a general population. PATIENTS: Twelve hundred and twelve subjects, men and women, between 20 and 69 years old without thyroid disease not treated with drugs interfering with thyroid function or analysis of TSH were included. MEASUREMENTS: Clinical signs of cardiovascular disease based on a questionnaire and medical records and laboratory analysis of lipids, atherothrombotic risk markers, C-reactive protein and TSH.
RESULTS: The main findings were a high incidence of subclinical hypothyroidism (19.7%) in a general population. Subclinical hypothyroidism was associated with higher concentrations of triglycerides and C-reactive protein. Below 50 years of age cardiovascular disease was more frequent in males with subclinical hypothyroidism compared to euthyroid males. Subclinical hypothyroidism was a predictor of cardiovascular disease in males below 50 years with an odds ratio of 3.4 (95% confidence interval 1.6-6.8) for developing cardiovascular disease compared to euthyroid age-matched males.
CONCLUSION: Our study demonstrates that patients with subclinical hypothyroidism have increased levels of triglycerides and signs of low-grade inflammation (raised C-reactive protein levels) and that subclinical hypothyroidism might be a risk factor for development of cardiovascular disease in younger males.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272919     DOI: 10.1111/j.1365-2265.2004.02088.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  49 in total

1.  Are hsCRP Levels and LDL/HDL Ratio Better and Early Markers to Unmask Onset of Dyslipidemia and Inflammation in Asymptomatic Subclinical Hypothyroidism?

Authors:  Mala Mahto; Baidarbhi Chakraborthy; Srinivas H Gowda; Harneet Kaur; Gaurav Vishnoi; Pramod Lali
Journal:  Indian J Clin Biochem       Date:  2012-04-18

2.  Effect of L-thyroxine treatment versus a placebo on serum lipid levels in patients with sub-clinical hypothyroidism.

Authors:  Xue Li; Zhaowei Meng; Qiang Jia; Xiaojun Ren
Journal:  Biomed Rep       Date:  2016-08-25

3.  Persistent cellular metabolic changes after hemithyroidectomy for benign euthyroid goiter.

Authors:  Tina Toft Kristensen; Jacob Larsen; Palle Lyngsie Pedersen; Anne-Dorthe Feldthusen; Christina Ellervik; Søren Jelstrup; Jan Kvetny
Journal:  Eur Thyroid J       Date:  2014-03-12

4.  Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease.

Authors:  Huanhuan Chen; Qian Xi; Hao Zhang; Bin Song; Xiaoyun Liu; Xiaodong Mao; Jie Li; Hongmei Shen; Wei Tang; Jiaming Zhang; Zhiguo Wang; Yu Duan; Chao Liu
Journal:  Endocrine       Date:  2011-08-30       Impact factor: 3.633

5.  The prevalence and determinants of hypothyroidism in hospitalized patients with type 2 diabetes mellitus.

Authors:  Fei Song; Cuiping Bao; Meiyu Deng; Hui Xu; Meijuan Fan; Stéphanie Paillard-Borg; Weili Xu; Xiuying Qi
Journal:  Endocrine       Date:  2016-09-07       Impact factor: 3.633

6.  Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  J Gen Intern Med       Date:  2018-08       Impact factor: 5.128

7.  Thyroid status, cardiovascular risk, and mortality in older adults.

Authors:  Anne R Cappola; Linda P Fried; Alice M Arnold; Mark D Danese; Lewis H Kuller; Gregory L Burke; Russell P Tracy; Paul W Ladenson
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

8.  Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter.

Authors:  Lindsey R Boone; William R Lagor; Margarita de la Llera Moya; Melissa I Niesen; George H Rothblat; Gene C Ness
Journal:  Atherosclerosis       Date:  2011-05-06       Impact factor: 5.162

9.  Perturbation of lipids and glucose metabolism associated with previous 2,4-D exposure: a cross-sectional study of NHANES III data, 1988-1994.

Authors:  Dina M Schreinemachers
Journal:  Environ Health       Date:  2010-02-26       Impact factor: 5.984

Review 10.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.